New York’s budget plan would apply a 75% wholesale tax to nicotine pouches, raising projected revenue

Jan.21
New York’s budget plan would apply a 75% wholesale tax to nicotine pouches, raising projected revenue
New York Gov. Kathy Hochul is proposing to tax ZYN nicotine pouches and other nicotine products at the same rate as cigarettes, applying a 75% wholesale tax under her proposed $260 billion state budget.

 

Key Takeaways

 

 

• New York Gov. Kathy Hochul proposes taxing ZYN and other nicotine pouches under the state budget

• The proposal would apply a 75% wholesale tax, projected to raise $18 million and then $44 million when fully implemented

• Philip Morris says the tax raises public health and affordability concerns and could make it harder for adults to switch from cigarettes

• Rutgers researcher Cristine Delnevo argues for an evidence-based, differentiated tax — above zero but below cigarettes

• The report includes product details on ZYN strengths and flavors and notes concerns about underage use

 


 

2Firsts, January 21, 2026

 

According to the New York Post, New York Gov. Kathy Hochul is pushing a plan to tax ZYN nicotine pouches and other nicotine products at the same rate as cigarettes. Under Hochul’s proposed $260 billion state budget, the pouches would face a 75% wholesale tax, a move projected to generate $18 million in the fiscal year beginning April 1 and $44 million when fully implemented the following year.

 

The report says critics argue the tax could undercut alternatives they view as less harmful than smoking. A spokesperson for Philip Morris, the manufacturer of ZYN, said the new tax “raises serious concerns from both a public health and affordability standpoint.”

 

The report notes that ZYN was the first nicotine pouch approved for sale by the U.S. Food and Drug Administration (FDA) last January. Philip Morris said about 1.4 million New Yorkers still smoke cigarettes, and it said smoking rates are highest among low-income and less-educated households. The company statement said a tax “of this magnitude” makes it harder for adults to switch off cigarettes, while also praising Hochul for putting “improving public health and affordability” at the center of her agenda and expressing interest in working with her administration and the legislature.

 

The report quotes Cristine Delnevo, director at the Rutgers University Institute for Nicotine & Tobacco Studies, saying: “Tax policy should reflect relative risk,” and warning that taxing nicotine pouches the same as cigarettes “could undermine harm reduction,” while leaving them untaxed “could encourage youth uptake.” She advocated “a differentiated, evidence-based tax—above zero but below cigarettes.”

 

The report also cites Richard Marianos, director of the Tobacco Law Enforcement Network and a former official with the Bureau of Alcohol, Tobacco Firearms and Explosives, who urged a focus on cracking down on criminal networks selling illegal cigarettes and higher-nicotine vapes, adding: “The tax is counterproductive because people won’t have an alternative.”

 

The report references a recent discussion sparked by an article in the Journal of the American Medical Association titled, “Can Nicotine Pouches Help People Quit Smoking?” It also describes ZYN pouches as being placed between the lip and gum, sold in 3-mg or 6-mg strengths, and available in flavors including coffee, menthol, peppermint and cinnamon. It quotes Jonathan Foulds, a professor at Penn State University, in JAMA discussing interest in using “a less harmful nicotine product like pouches” to reduce smoking.

 

On the other side, the report says critics fear nicotine pouches could become a new trend like vaping and see an explosion in use among underage users.

 

Photo credit: New York Post

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

22nd Century Positions VLN® Cigarettes for Growth as FDA Considers 0.7 mg/g Nicotine Cap
22nd Century Positions VLN® Cigarettes for Growth as FDA Considers 0.7 mg/g Nicotine Cap
22nd Century Group (Nasdaq: XXII) reported early commercial momentum for its FDA-authorized VLN® very low nicotine cigarettes, distributing approximately 8,800 cartons across 1,700 new U.S. retail outlets in the fourth quarter of 2025, while forecasting expansion to more than 5,000 retail points in 2026.
Business
Feb.24
Study Says Europe’s Illicit Disposable Vape Market to Reach EUR 6.6 Billion in 2026
Study Says Europe’s Illicit Disposable Vape Market to Reach EUR 6.6 Billion in 2026
A new study by the Fraunhofer Institute says the rapidly expanding illicit market for disposable e-cigarettes is undermining European regulation, fuelling youth vaping and causing significant tax losses. The study says the illicit market is worth EUR 6.6 billion in 2026 and is projected to rise to EUR 10.8 billion by 2030. It adds that a significant share of the disposable vape market now operates outside the regulatory framework established by the EU Tobacco Products Directive.
Mar.13 by 2FIRSTS.ai
Reynolds Appeals ITC Defeat in Disposable Vape Section 337 Case to U.S. Federal Circuit
Reynolds Appeals ITC Defeat in Disposable Vape Section 337 Case to U.S. Federal Circuit
On March 13, 2026, R.J. Reynolds and related companies filed an appeal with the U.S. Court of Appeals for the Federal Circuit, seeking review of the U.S. International Trade Commission’s final ruling in the disposable vape Section 337 investigation.
Mar.16 by 2FIRSTS.ai
Product | VOZOL launches new GEAR-series device in the UK and UAE, featuring a 2.1-inch colour screen and sound interaction
Product | VOZOL launches new GEAR-series device in the UK and UAE, featuring a 2.1-inch colour screen and sound interaction
Vape brand VOZOL has recently listed a disposable shisha-style product, the GEAR HOOKAH 40000, on its official website. Public information shows the device comes with a 26ml e-liquid capacity, offers 3mg/ml and 5mg/ml nicotine strengths, and is marketed at 25,000–40,000 puffs. It is currently available via selected online retail channels in the UK and the UAE.
Feb.04 by 2FIRSTS.ai
FDA Says Flavored ENDS Must Show “Added Benefit” as Small Manufacturers Seek Clearer Switching Benchmarks
FDA Says Flavored ENDS Must Show “Added Benefit” as Small Manufacturers Seek Clearer Switching Benchmarks
During the FDA PMTA roundtable session on “Studies of Adult Benefit,” officials said flavored ENDS must demonstrate “added benefit” over tobacco-flavored products under the APPH standard, including sustained complete switching evidence. Small manufacturers questioned switching benchmarks, study duration, and bridging expectations.
Feb.11
Haypp Voluntarily Sets a 20 mg Nicotine-Strength Cap for Nicotine Pouches and Urges the UK to Establish a Regulatory Limit
Haypp Voluntarily Sets a 20 mg Nicotine-Strength Cap for Nicotine Pouches and Urges the UK to Establish a Regulatory Limit
Online nicotine pouch retailer Haypp said it has voluntarily adopted a 20 mg per pouch nicotine-strength cap across its e-commerce platforms and is urging the UK government to formalize that cap as the limit as it develops a regulatory framework. Haypp said proportionate limits would protect consumers while preserving nicotine pouches as a viable reduced-risk alternative to cigarettes.
Feb.26 by 2FIRSTS.ai